Loss of LKB1 protects against acetaminophen hepatotoxicity in mice through sex-specific mechanisms

Clicks: 1
ID: 337682
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #151 of 151 articles by views in toxicological sciences : an official journal of the society of toxicology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 151 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Acetaminophen (APAP) overdose is a major cause of acute liver failure (ALF). We previously observed activation of liver kinase B1 (LKB1) in non-surviving patients with APAP-induced ALF. Thus, we hypothesized LKB1 is detrimental in APAP hepatotoxicity. To test our hypothesis, we overdosed hepatocyte-specific LKB1 knockout (KO) mice and wildtype (WT) littermates with APAP and measured liver injury 2, 6, and 24 h later. Consistent with our hypothesis, LKB1 KO protected against APAP hepatotoxicity. However, the mechanisms of protection were sex-specific. Male KOs had lower NAPQI formation due to lower mitochondrial CYP2E1. In contrast, NAPQI formation was similar between female KO and WT mice, but female KOs still had reduced oxidative stress. The pentose phosphate pathway (PPP) is a major source of NADPH to counter oxidative stress, so we hypothesized that female KO mice have increased PPP enzymes. To test that, we measured hepatic glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme in the oxidative PPP. Importantly, G6PD was increased in female WT mice compared to male WT animals and even further increased in the female KO mice. Furthermore, 1.5 h post-treatment with the G6PD activator AG1 protected against APAP and increased hepatic NADPH in WT animals. Finally, re-analysis of our prior proteomics data revealed LKB1 activation occurred in both male and female ALF non-survivors, though it was greater in males. We conclude LKB1 regulates CYP2E1 and the PPP, that mitochondrial CYP2E1 is critical in APAP toxicity, and PPP activation is a potential therapeutic approach in liver injury in men and women.
Reference Key
openalex_W7224274376 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Debasree Bhadra, Jenna S Caswell, Kathryn L Smith, Natalie Porat‐Shliom, Mitchell R. McGill
Journal toxicological sciences : an official journal of the society of toxicology
Year 2026
DOI
10.1093/toxsci/kfag144
URL
https://doi.org/10.1093/toxsci/kfag144
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.